Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
OBJECTIVE This study was conducted to describe the incidence of diabetes following pancreatic disease, assess how these patients are classified by clinicians, and compare clinical characteristics with type 1 and type 2 diabetes. RESEARCH DESIGN AND METHODS Primary care records in England (n = 2,360,631) were searched for incident cases of adult-onset diabetes between 1 January 2005 and 31 March 2016. We examined demographics, diabetes classification, glycemic control, and insulin use in those with and without pancreatic disease (subcategorized into acute pancreatitis or chronic pancreatic disease) before diabetes diagnosis. Regression analysis was used to control for baseline potential risk factors for poor glycemic control (HbA1c ≥7% [53 mmol/mol]) and insulin requirement. RESULTS We identified 31,789 new diagnoses of adult-onset diabetes. Diabetes following pancreatic disease (2.59 [95% CI 2.38–2.81] per 100,000 person-years) was more common than type 1 diabetes (1.64 [1.47–1.82]; P < 0.001). The 559 cases of diabetes following pancreatic disease were mostly classified by clinicians as type 2 diabetes (87.8%) and uncommonly as diabetes of the exocrine pancreas (2.7%). Diabetes following pancreatic disease was diagnosed at a median age of 59 years and BMI of 29.2 kg/m2. Diabetes following pancreatic disease was associated with poor glycemic control (adjusted odds ratio, 1.7 [1.3–2.2]; P < 0.001) compared with type 2 diabetes. Insulin use within 5 years was 4.1% (3.8–4.4) with type 2 diabetes, 20.9% (14.6–28.9) with diabetes following acute pancreatitis, and 45.8% (34.2–57.9) with diabetes following chronic pancreatic disease. CONCLUSIONS Diabetes of the exocrine pancreas is frequently labeled type 2 diabetes but has worse glycemic control and a markedly greater requirement for insulin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A distinguishing feature is concurrent pancreatic exocrine insuf fi ciency (consider screening individuals with acute and chronic pancreatitis for exocrine pancreatic insuf fi ciency by measuring fecal elastase), pathological pancreatic imaging (endoscopic ultrasound, MRI, and computed tomography), and absence of type 1 diabetes -associated autoimmunity (116 -120).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [117]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181 · cited 1×
“diabetes without preceding pancreatic disease, diabetes after acute pancreatitis, and diabetes after chronic pancreatic disease (27).”
BackgroundRegression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 1×
“We initially created Cox proportional hazards models to assess the hazard of progression to insulin; however, these failed proportional hazards testing (28,29).”
MethodInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066 · cited 1×
“control as HbA1c $7% (53 mmol/mol), according to the generic target of the American Diabetes Association and the European Association for the Study of Diabetes hyperglycemia guidelines (24).”
MethodThe Regression Analysis of Binary Sequences
Cox, D. R. (1958) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1958.tb00292.x · Cited by 2,813 · cited 1×
“We created logistic regression models for odds of poor glycemic control at 1 year and at 5 years (26).”
MethodType 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
Hart, P. A., Bellin, M. D., Andersen, D. K., Bradley, D., Cruz-Monserrate, Z., Forsmark, C. E., Goodarzi, M. O., Habtezion, A., Korc, M., Kudva, Y. C., et al. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30106-6 · Cited by 551
Natural Course in Chronic Pancreatitis
Lankisch, P. G., Löhr-Happe, A., Otto, J., & Creutzfeldt, W. (1993) · Digestion · doi:10.1159/000201029 · Cited by 452 · cited 1×
“This form of diabetes results when a process, such as inflammation, neoplasia, or surgical resection, disrupts the global architecture or physiology of the pancreas, often resulting in both exocrine and endocrine dysfunction (2,3).”
BackgroundNewly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis
Das, S. L. M., Singh, P. P., Phillips, A. R. J., Murphy, R., Windsor, J. A., & Petrov, M. S. (2014) · Gut · doi:10.1136/gutjnl-2013-305062 · Cited by 401 · cited 1×
“sulin if monitored beyond 5 years (17).”
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Global epidemiology and holistic prevention of pancreatitis
Petrov, M. S., & Yadav, D. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0087-5 · Cited by 915
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Rodacki, M., Teles, M. G., Gabbay, M. A. L., Montenegro, R. M., & Bertoluci, M. C. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-1 · Cited by 197
Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions
Hart, N. J., & Powers, A. C. (2018) · Diabetologia · doi:10.1007/s00125-018-4772-2 · Cited by 167
Zhi, M., Zhu, X., Lugea, A., Waldron, R. T., Pandol, S. J., & Li, L. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00637 · Cited by 139
“(Expert Committee on the and Classification of Diabetes, 2003; American Diabetes, 2011) Type 3c diabetes is not a single entity as it results from several different exocrine pancreatic diseases including acute, relapsing, and chronic pancreatitis of any etiology, hemochromatosis, cystic fibrosis, fibrocalculous pancre…”
BackgroundThe epidemiology of alopecia areata: a population‐based cohort study in UK primary care*
Harries, M. J., Macbeth, A. E., Holmes, S., Chiu, W. S., Gallardo, W. R., Nijher, M., de Lusignan, S., Tziotzios, C., & Messenger, A. G. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20628 · Cited by 147
Hinton, W., McGovern, A. P., Coyle, R. M., Han, T. S., Sharma, P., Correa, A., Ferreira, F. M., & de Lusignan, S. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020282 · Cited by 134
Self-citationTobacco and alcohol as risk factors for pancreatic cancer
Korc, M., Jeon, C. Y., Edderkaoui, M., Pandol, S. J., & Petrov, M. S. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.001 · Cited by 116
“Large prospective cohort studies of individuals at high risk of pancreatic cancer, such as patients with pancreatitis or diabetes of the exocrine pancreas [53-55], will provide opportunities to accurately measure exposure to smoking and alcohol in a standardized manner and allow for an analysis of the synergistic impa…”
BackgroundDiabetes following acute pancreatitis
Hart, P. A., Bradley, D. P., Conwell, D. L., Dungan, K. M., Krishna, S. G., Wyne, K. L., Bellin, M. D., Yadav, D. K., Andersen, D. K., Serrano, J., et al. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00019-4 · Cited by 114
Yadav, D., Park, W. G., Fogel, E. L., Li, L., Chari, S. T., Feng, Z., Fisher, W. E., Forsmark, C. E., Jeon, C. Y., Habtezion, A., et al. (2018) · Pancreas · doi:10.1097/mpa.0000000000001170 · Cited by 103
“The clinical significance of pancreatogenic (type 3c) diabetes is beginning to be recognized.(22,23) Although CP increases the risk of osteoporosis and fractures, the underlying mechanisms are yet to be elucidated.”
Backgroundde Lusignan, S., Alexander, H., Broderick, C., Dennis, J., McGovern, A. P., Feeney, C., & Flohr, C. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13784 · Cited by 108
Self-citationThierens, N. D. E., Verdonk, R. C., Löhr, M. J., van Santvoort, H. C., Bouwense, S. A. W., & van Hooft, J. E. (2024) · The Lancet · doi:10.1016/s0140-6736(24)02187-1 · Cited by 115
Acute pancreatitis and diabetes mellitus: a review
Richardson, A., & Park, W. G. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.505 · Cited by 105
“A diagnosis of diabetes mellitus - Evidence of exocrine pancreatic insufficiency (fecal elastase 1 [FE1] 200 μg/g or abnormal direct function testing) - Abnormal pancreatic imaging (endoscopic ultrasound, magnetic resonance imaging, and computed tomography) - Absence of T1DM associated autoimmune markers (antibodies a…”
BackgroundInfluentialPancreas volume in health and disease: a systematic review and meta-analysis
DeSouza, S. V., Singh, R. G., Yoon, H. D., Murphy, R., Plank, L. D., & Petrov, M. S. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1496015 · Cited by 97
“the exocrine pancreas in the remaining studies on associations between diabetes status and PV was minimal as diabetes of the exocrine pancreas is dwarfed by T2DM in adults [57,58].”
BackgroundCho, J., Scragg, R. K. R., & Petrov, M. S. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000225 · Cited by 93
Diabetes of the exocrine pancreas
Wynne, K., Devereaux, B., & Dornhorst, A. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14451 · Cited by 87
Irving, P. M., de Lusignan, S., Tang, D., Nijher, M., & Barrett, K. J. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2020-000573 · Cited by 83
Bharmal, S. H., Cho, J., Ramos, G. C. A., Ko, J., Stuart, C. E., Modesto, A. E., Singh, R. G., & Petrov, M. S. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01682-y · Cited by 79
Cho, J., Scragg, R. K. R., & Petrov, M. S. (2020) · Diabetes Care · doi:10.2337/dc20-0207 · Cited by 81
“poor glycemic control (defined as HbA1c $7% [53 mmol/mol]) compared with those with T2D (9).”
BackgroundChronic Pancreatitis: Epidemiology, Diagnosis, and Management Updates
Kichler, A., & Jang, S. N. (2020) · Drugs · doi:10.1007/s40265-020-01360-6 · Cited by 81
“It is important to distinguish diabetes type 3c from type 2, as it is associated with worst glycemic control with greater insulin demands [161, 162].”
BackgroundLynam, A., McDonald, T., Hill, A., Dennis, J., Oram, R., Pearson, E., Weedon, M., Hattersley, A., Owen, K., Shields, B., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031586 · Cited by 72
Type-3c Diabetes Mellitus, Diabetes of Exocrine Pancreas - An Update
Bhattamisra, S. K., Siang, T. C., Rong, C. Y., Annan, N. C., Sean, E. H. Y., Xi, L. W., Lyn, O. S., Liew, H. S., Choudhury, H., Pandey, M., et al. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190115145702 · Cited by 80
Kumar, H., DeSouza, S. V., & Petrov, M. S. (2019) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2019.07.002 · Cited by 68
Cho, J., Scragg, R., Pandol, S. J., Goodarzi, M. O., & Petrov, M. S. (2019) · Diabetes Care · doi:10.2337/dc19-0145 · Cited by 69
“showed that insulin is used frequently in this population (6).”
BackgroundInfluentialIrving, P., Barrett, K., Nijher, M., & de Lusignan, S. (2021) · Evidence-Based Mental Health · doi:10.1136/ebmental-2020-300223 · Cited by 63
Panorama of mediators in postpancreatitis diabetes mellitus
Petrov, M. S. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000654 · Cited by 61
Abbruzzese, J. L., Andersen, D. K., Borrebaeck, C. A. K., Chari, S. T., Costello, E., Cruz‐Monserrate, Z., Eibl, G., Engleman, E. G., Fisher, W. E., Habtezion, A., et al. (2018) · Pancreas · doi:10.1097/mpa.0000000000001037 · Cited by 58
“The symposium was organized around 4 sessions designed to examine these complex relationships: (1) The Role of Altered Energy Metabolism in PDAC, (2) PDAC as a Cause of Diabetes, (3) Obesity as a Cause/Risk Factor for PDAC, and (4) Inflammation and the Immune System as a Cause/Mediator of PDAC.”
MethodGenetic Risk Score in Diabetes Associated With Chronic Pancreatitis Versus Type 2 Diabetes Mellitus
Goodarzi, M. O., Nagpal, T., Greer, P. J., Cui, J., Chen, Y. I., Guo, X., Pankow, J. S., Rotter, J. I., Alkaade, S., Amann, S. T., et al. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000057 · Cited by 59
Lee, M., Sun, J., Han, M., Cho, Y., Lee, J., Nam, C. M., & Kang, E. S. (2019) · Diabetes Care · doi:10.2337/dc18-2195 · Cited by 58
“been reported to be closely associated (36), and patients with uncontrolled hyperglycemia were much more likely to develop pancreatic cancer than those with well-controlled hyperglycemia (35,37).”
BackgroundNikiphorou, E., de Lusignan, S., Mallen, C. D., Roberts, J., Khavandi, K., Bedarida, G., Buckley, C. D., Galloway, J. B., & Raza, K. (2019) · Rheumatology · doi:10.1093/rheumatology/kez409 · Cited by 53
Hart, P. A., Andersen, D. K., Mather, K. J., Castonguay, A. C., Bajaj, M., Bellin, M. D., Bradley, D., Contreras, N., Habtezion, A., Korc, M., et al. (2018) · Pancreas · doi:10.1097/mpa.0000000000001168 · Cited by 46
Pathological Mechanisms in Diabetes of the Exocrine Pancreas: What’s Known and What’s to Know
Wei, Q., Qi, L., Lin, H., Liu, D., Zhu, X., Dai, Y., Waldron, R. T., Lugea, A., Goodarzi, M. O., Pandol, S. J., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.570276 · Cited by 58
Diabetes in chronic pancreatitis: risk factors and natural history
Goodarzi, M. O., Petrov, M. S., Andersen, D. K., & Hart, P. A. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000756 · Cited by 45
Shivaprasad, C., Aiswarya, Y., Kejal, S., Sridevi, A., Anupam, B., Ramdas, B., Gautham, K., & Aarudhra, P. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819860133 · Cited by 42
“Recent reports suggest that cases of pancreatogenic diabetes are often misclassified as T2D with potential long-term implications.(24,25) Our results indicate that FCPD, compared with T2D, is associated with elevated GV as indicated by important measures of GV, such as MAGE, SD, CONGA, and %CV.”
ResultBashir, B., Ho, J. H., Downie, P., Hamilton, P., Ferns, G. A., Datta, D. B. N., Cegla, J., Wierzbicki, A. S., Dawson, C., Jenkinson, F., et al. (2023) · Metabolites · doi:10.3390/metabo13050621 · Cited by 52
“Development of new-onset diabetes due to recurrent pancreatitis [64], insulin resistance as a consequence of hypertriglyceridaemia, and pro-inflammatory milieu [65] may adversely impact cardiovascular risk profile and, therefore, prospective long-term follow-up studies are warranted to investigate the true incidence o…”
BackgroundViggers, R., Jensen, M. H., Laursen, H. V. B., Drewes, A. M., Vestergaard, P., & Olesen, S. S. (2021) · Diabetes Care · doi:10.2337/dc21-0333 · Cited by 47
Oldfield, L. S., Evans, A., Rao, R. G., Jenkinson, C., Purewal, T. S., Psarelli, E. E., Menon, U., Timms, J. F., Pereira, S. P., Ghaneh, P., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2021.103802 · Cited by 45
Dugic, A., Hagström, H., Dahlman, I. A., Rutkowski, W., Daou, D., Kulinski, P., Löhr, M. J., & Vujasinović, M. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12344 · Cited by 43
“1%).(11,21,22) In our cohort, 23% of patients had type 2 diabetes at the time of CP diagnosis, whereas an additional 13% developed PPDM after 10 years.”
Ko, J., Skudder‐Hill, L., Cho, J., Bharmal, S. H., & Petrov, M. S. (2020) · Nutrients · doi:10.3390/nu12092883 · Cited by 40
“Several studies have demonstrated that there are differences between NODAP and T2DM in the gut hormone response [8], blood glucose control [9], risk of pancreatic cancer [10], risk of mortality [11], and survival benefit following the use of common antidiabetic medications [12,13].”
BackgroundWITHDRAWN: Reprint of: Classification of diabetes mellitus
Adler, A., Bennett, P., Chair, S. C., Gregg, E., Venkat Narayan, K. M., Schmidt, M. I., Sobngwi, E., Tajima, N., Tandon, N., Unwin, N., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108972 · Cited by 38
RetractedRisk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study
Galloway, J. B., Barrett, K. J., Irving, P. M., Khavandi, K., Nijher, M., Nicholson, R., de Lusignan, S., & Buch, M. H. (2020) · RMD Open · doi:10.1136/rmdopen-2020-001392 · Cited by 38
Olesen, S. S., Viggers, R., Drewes, A. M., Vestergaard, P., & Jensen, M. H. (2022) · Diabetes Care · doi:10.2337/dc21-2531 · Cited by 38
Marchetti, P., Suleiman, M., & Marselli, L. (2018) · Diabetologia · doi:10.1007/s00125-018-4546-x · Cited by 41
“At the same time, a number of limitations should be taken into account, such as the possible presence of diabetes caused by the underlying disorder of the exocrine pancreas (type 3c diabetes, which may be erroneously classified as type 2 diabetes) [19, 20], the limited amount of tissue yielded, the variable regions of…”
Pendharkar, S. A., Singh, R. G., Bharmal, S. H., Drury, M., & Petrov, M. S. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001145 · Cited by 37
“19 (3) Had NODAP, using the criteria recommended by the American Diabetes Association guidelines: HbA1c ≥ 39 mmol/mol (≥ 5.”
BackgroundMethodChildhood Pancreatitis and Risk for Incident Diabetes in Adulthood
Bendor, C. D., Bardugo, A., Zucker, I., Cukierman‐Yaffe, T., Lutski, M., Derazne, E., Shohat, T., Mosenzon, O., Tzur, D., Sapir, A., et al. (2019) · Diabetes Care · doi:10.2337/dc19-1562 · Cited by 36
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., & Rosenblum, N. D. (2021) · Diabetes Care · doi:10.2337/dci21-0051 · Cited by 40
Ciochina, M., Balaban, D. V., Mănucu, G., Jinga, M., & Gheorghe, C. (2022) · Biomolecules · doi:10.3390/biom12050618 · Cited by 40
“[4] revealed that insulin use within 5 years of the diagnosis of DM was significantly higher in T3cDM (20.”
BackgroundMetabolic Sequelae: The Pancreatitis Zeitgeist of the 21st Century
Petrov, M. S., & Olesen, S. S. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.07.025 · Cited by 36
Zhang, J., Lv, Y., Hou, J., Zhang, C., Yua, X., Wang, Y., Yang, T., Su, X., Ye, Z., & Li, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-31947-4 · Cited by 37
“The exocrine pancreatic disease can lead to diabetes of the exocrine pancreas (DEP), the second most common type of new-onset diabetes in adults (surpassing type 1 diabetes) 10 .”
BackgroundFrequency and risk factors for mental disorders following pancreatitis: a nationwide cohort study
Cho, J., Walia, M., Scragg, R. K. R., & Petrov, M. S. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1560748 · Cited by 32
Use of Insulin and the Risk of Progression of Pancreatitis: A Population‐Based Cohort Study
Cho, J., Scragg, R. K. R., & Petrov, M. S. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1644 · Cited by 30
Singh, A., Aggarwal, M., Garg, R., Stevens, T., & Chahal, P. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2090601 · Cited by 33
“Diabetes secondary to diseases of the exocrine pancreas (DEP) or ‘pancreatogenic’ diabetes constitutes 1.6%–1.8% of new-onset diabetes in adults in comparison with 1.1% for type1DM (T1DM) [8].”
BackgroundResultInfluentialLemańska, A., Price, C. A., Jeffreys, N., Byford, R. C., Dambha‐Miller, H., Fan, X., Hinton, W., Otter, S., Rice, R., Stunt, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275369 · Cited by 35
“Older age, diabetes mellitus, chronic pancreatitis, and gallbladder disease are established risk factors [5].”
BackgroundSelf-citationThe Cause and Effect Relationship of Diabetes after Acute Pancreatitis
Śliwińska‐Mossoń, M., Bil‐Lula, I., & Marek, G. (2023) · Biomedicines · doi:10.3390/biomedicines11030667 · Cited by 39
“More stringent diagnostic standards were proposed by Ewald and Bretzel [26], but these were criticized because they are difficult to implement clinically [49–52].”
BackgroundRisk factors for diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis
Zahariev, O. J., Bunduc, Ș., Kovács, A., Demeter, D., Havelda, L., Budai, B. C., Veres, D. S., Hosszúfalusi, N., Erőss, B. M., Teutsch, B., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1257222 · Cited by 29
Cho, J., Pandol, S. J., & Petrov, M. S. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01683-0 · Cited by 28
Pancreatic regional blood flow links the endocrine and exocrine diseases
Rizk, A. A., Dybala, M. P., Rodriguez, K. C., Rupnik, M. S., & Hara, M. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166185 · Cited by 29
“Type 3c diabetes (T3cD) refers to diabetes following pancreatic diseases such as pancreatitis, pancreas removal, cystic fibrosis (CF) and hemochromatosis (19).”
InfluentialClassification of diabetes. World Health Organization 2019. What’s new?
Кононенко, И. В., Smirnova, O. M., Mayorov, A. Y., & Shestakova, M. V. (2020) · Diabetes Mellitus · doi:10.14341/dm12405 · Cited by 40
Post-acute pancreatitis diabetes: A complication waiting for more recognition and understanding
García‐Compeán, D., Jiménez-Rodríguez, A. R., Muñoz-Ayala, J. M., González, J. A., Maldonado-Garza, H. J., & Villarreal‐Pérez, J. Z. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i28.4405 · Cited by 26
Prevalence and Risk Factors for Pancreatic Insufficiency After Partial Pancreatectomy
Thomas, A. S., Huang, Y., Kwon, W., Schrope, B., Sugahara, K. N., Chabot, J. A., Wright, J. D., & Kluger, M. D. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-022-05302-3 · Cited by 28
Gut Hormone Responses to Mixed Meal Test in New-Onset Prediabetes/Diabetes After Acute Pancreatitis
Pendharkar, S. A., Singh, R. G., Cervantes, A., DeSouza, S. V., Bharmal, S. H., & Petrov, M. S. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0802-9569 · Cited by 24
“For instance, 93 % of all cases of diabetes of the exocrine pancreas (DEP) [4], which is the second most common type of adult-onset diabetes and is characterised by significantly higher glycated haemoglobin (HbA1c) levels compared with type 2 diabetes, are misdiagnosed as type 2 diabetes [3].”
BackgroundInfluentialLin, C., Yeh, N.-C., Wang, J., Ho, C., Her, S.-H., Tsay, W., & Chien, C.-C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa035 · Cited by 25
Oxyntomodulin May Distinguish New-Onset Diabetes After Acute Pancreatitis From Type 2 Diabetes
Bharmal, S. H., Cho, J., Stuart, C. E., Ramos, G. C. A., Ko, J., & Petrov, M. S. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000132 · Cited by 24
Bao, J., Liu, D., Sun, J., Su, X., Cheng, H., Qi, L., Zhang, Y., Lv, Y., Ye, Z., Yu, X., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109223 · Cited by 25
Diabetes of the Exocrine Pancreas: Implications for Pharmacological Management
Goodarzi, M. O., & Petrov, M. S. (2023) · Drugs · doi:10.1007/s40265-023-01913-5 · Cited by 29
“8%) occurred after pancreatic disease and were deemed DEP [21].”
BackgroundResultInfluentialLv, Y., Zhang, J., Yang, T., Sun, J., Hou, J., Chen, Z., Yu, X., Yuan, X., Lu, X., Xie, T., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.903731 · Cited by 27
Zhang, J., Hou, J., Liu, D., Lv, Y., Zhang, C., Su, X., & Li, L. (2022) · International Journal of Endocrinology · doi:10.1155/2022/7764963 · Cited by 29
“0e exocrine pancreatic disease can lead to diabetes of the exocrine pancreas (DEP), which is the second most common type of new-onset diabetes in adults (surpassing type 1 diabetes) [1].”
BackgroundTu, X., Liu, Q., Chen, L., Li, J., Yu, X., Jiao, X., Wang, N., Hu, L., Yuanyuan, Gong, W., et al. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01840-0 · Cited by 24
Pancreatic Cancer: A Review of Risk Factors
Grigorescu, R. R., Husar-Sburlan, I. A., & Gheorghe, C. (2024) · Life · doi:10.3390/life14080980 · Cited by 29
“More studies are needed to determine whether and how coffee consumption is associated with PC risk.”
Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus
Hart, P. A., Andersen, D. K., Petrov, M. S., & Goodarzi, M. O. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000754 · Cited by 24
“It has previously been estimated that approximately 2–9% of all patients with diabetes have an underlying pancreatic disease and that up to 90% are originally diagnosed with T2DM [2,3].”
BackgroundInfluentialLindkvist, B., Nilsson, C. A. M., Kvarnström, M., & Oscarsson, J. (2018) · Pancreatology · doi:10.1016/j.pan.2018.05.483 · Cited by 22
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., & Rosenblum, N. D. (2021) · Diabetes · doi:10.2337/db21-0777 · Cited by 22
Lee, N., Park, S. J., Kang, D., Jeon, J. Y., Kim, H. J., Kim, D. J., Lee, K. W., Boyko, E. J., & Han, S. J. (2021) · Diabetes Care · doi:10.2337/dc21-1659 · Cited by 21
The spectrum of diabetes in acute and chronic pancreatitis
Olesen, S. S., Toledo, F. G. S., & Hart, P. A. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000864 · Cited by 22
Development of a Clinical Prediction Model for Diabetes in Chronic Pancreatitis: The PREDICT3c Study
Jeon, C. Y., Hart, P. A., Li, L., Yang, Y., Chang, E., Bellin, M. D., Fisher, W. E., Fogel, E. L., Forsmark, C. E., Park, W. G., et al. (2022) · Diabetes Care · doi:10.2337/dc22-1414 · Cited by 22
Bureš, J., Kohoutová, D., Škrha, J., Bunganič, B., Ngo, O., Suchánek, Š., Škrha, P., & Zavoral, M. (2023) · Cancers · doi:10.3390/cancers15143669 · Cited by 24
“Rapid progression of hyperglycemia or an early need for insulin should also prompt to consider this diagnosis [126].”
BackgroundDiabetes mellitus Typ 3c – Prävalenz, Diagnose, Besonderheiten der Therapie
Bojunga, J., & Schlereth, F. (2018) · Der Diabetologe · doi:10.1007/s11428-018-0346-7 · Cited by 24
“In einer aktuellen Studie wurden 559 Fälle von Diabetes nach Pankreaserkrankungen ebenfalls meist falsch als Typ-2-Diabetes (87,8%) und nur gelegentlich korrekt als pankreopriver Diabetes (2,7%) klassifiziert [7].”
BackgroundPancreatitis: summary of NICE guidance
Samarasekera, E. J., Mahammed, S., Carlisle, S., & Charnley, R. (2018) · BMJ · doi:10.1136/bmj.k3443 · Cited by 19
Olesen, S. S., Svane, H. M. L., Nicolaisen, S. K., Kristensen, J. K., Drewes, A. M., Brandslund, I., Beck‐Nielsen, H., Nielsen, J. S., & Thomsen, R. W. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13210 · Cited by 19
“Also, most experts recommend that biguanides are prescribed in PPDM as these have been associated with a survival benefit in this context.7 Notwithstanding this recommendation, we observed that patients with PPDM less frequently received a biguanide prescription compared to individuals with T2D.”
BackgroundInfluentialIdentification of a Risk Profile for New-Onset Diabetes After Acute Pancreatitis
Firkins, S. A., Hart, P. A., Papachristou, G. I., Lara, L. F., Cruz‐Monserrate, Z., Hinton, A. M., Conwell, D. L., Bradley, D. P., & Krishna, S. G. (2021) · Pancreas · doi:10.1097/mpa.0000000000001818 · Cited by 17
“Finally, men (aOR, 1.20; 95% CI, 1.03–1.40), those with Elixhauser comorbidity index of 3 or higher (aOR, 1.47; 95% CI, 1.23–1.75), and those with associated nondiabetic metabolic syndrome (aOR, 2.12; 95% CI, 1.21–3.70) were more likely to experience AP-related DM.”
BackgroundInfluentialDavidsen, L., Jensen, M. H., Cook, M. E., Vestergaard, P., Knop, F. K., Drewes, A. M., & Olesen, S. S. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad175 · Cited by 21
Ko, J., Kimita, W., Skudder‐Hill, L., Li, X., Priya, S., Bharmal, S. H., Cho, J., & Petrov, M. S. (2021) · Pancreatology · doi:10.1016/j.pan.2021.01.018 · Cited by 19
Ko, J., Skudder‐Hill, L., Cho, J., Bharmal, S. H., & Petrov, M. S. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3357 · Cited by 17
Harries, M. J., Macbeth, A. E., Holmes, S., Thompson, A. R., Chiu, W. S., Gallardo, W. R., Messenger, A. G., Tziotzios, C., & de Lusignan, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045718 · Cited by 17
Type 1 Diabetes in Acute Pancreatitis Consortium
Serrano, J., Laughlin, M. R., Bellin, M. D., Yadav, D. K., Chinchilli, V. M., & Andersen, D. K. (2022) · Pancreas · doi:10.1097/mpa.0000000000002073 · Cited by 17
Oldfield, L. S., Stott, M. C., Hanson, R., Jackson, R., Reynolds, W. F., Chandran-Gorner, V., Meer, R. V. D., Alison, L. J., Tejeiro, R. A., Purewal, T. S., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-068010 · Cited by 20
Relationship between Gout and Diabetes Mellitus after Acute Pancreatitis: A Nationwide Cohort Study
Cho, J., Dalbeth, N., & Petrov, M. S. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.190487 · Cited by 16
“PPDM is the most common subtype of diabetes of the exocrine pancreas, which is in turn the second most common type of new-onset diabetes in adults 13,14,15 and is known to lead to higher risks of mortality and hospitalization compared with type 2 diabetes 16,17 .”
BackgroundPancreatectomy, Islet Cell Transplantation, and Nutrition Considerations
Narayanan, S., Bhutiani, N., Adamson, D. T., & Jones, C. M. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10578 · Cited by 16
Cho, J., Scragg, R. K. R., & Petrov, M. S. (2020) · HPB · doi:10.1016/j.hpb.2020.10.010 · Cited by 16
Dybala, M. P., Gebien, L. R., Reyna, M. E., Yu, Y. A., & Hara, M. (2020) · Diabetes · doi:10.2337/db20-0810 · Cited by 18
“7% of themwere classified as having T3c diabetes (52).”
BackgroundZhu, X., Liu, D., Li, G., Zhi, M., Sun, J., Qi, L., Li, J., Pandol, S. J., & Li, L. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111653 · Cited by 18
Acute and Chronic Alcoholic Pancreatitis, Including Paraduodenal Pancreatitis
Klöppel, G., & Zamboni, G. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2022-0202-ra · Cited by 15
Walker, A. R. P., O’Kelly, J., Graham, C., Nowell, S., Kidd, D., & Mole, D. J. (2022) · BJS Open · doi:10.1093/bjsopen/zrac148 · Cited by 15
Mastracci, T. L., Apte, M. V., Amundadottir, L. T., Alvarsson, A., Artandi, S. E., Bellin, M. D., Bernal‐Mizrachi, E., Caicedo, A., Campbell‐Thompson, M., Cruz‐Monserrate, Z., et al. (2023) · Diabetes · doi:10.2337/db22-0942 · Cited by 18
Metadata
- Authors
- Woodmansey, C., McGovern, A. P., McCullough, K. A., Whyte, M. B., Munro, N. M., Correa, A. C., Gatenby, P. A. C., Jones, S. A., & de Lusignan, S.
- Affiliations
- University of Surrey (GB)
- Royal Surrey County Hospital (GB)
- Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-31
- Volume
- 40
- Issue
- 11
- Pages
- 1486-1493
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2752023293
- Cited by
- 280
- References
- 36
- Citations by year
- 2026: 26 · 2025: 28 · 2024: 36 · 2023: 33 · 2022: 38 · 2021: 34 · 2020: 29 · 2019: 28 · 2018: 25 · 2017: 3
- FWCI
- 23.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Funders
- National Institute for Health and Care Research (ACF-2017-23-003)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 3c diabetes, type 2 diabetes, incidence, acute pancreatitis, chronic pancreatitis, glycemic control, insulin requirement, HbA1c, primary care records
- MeSH terms
- Acute Disease, Adult, Aged, Aged, 80 and over, Blood Glucose, Chronic Disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, England, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hyperglycemia, Insulin, Male, Middle Aged, Pancreatitis, Primary Health Care, Retrospective Studies, Risk Factors, Body Mass Index, Incidence, Pancreas, Exocrine, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.